Novel sst4-Selective Somatostatin (SRIF) Agonists. 4. Three-Dimensional Consensus Structure by NMR

Journal of Medicinal Chemistry

Volumn 46, Issue 26, 2003, Pages 5606-5618

  Grace, Christy Rani R ^a   Koerber, Steven C ^a   Erchegyi, Judit ^a   Reubi, Jean Claude ^b   Rivier, Jean ^a   Riek, Roland ^a  

^a SALK INSTITUTE FOR BIOLOGICAL STUDIES   (United States)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; AROMATIC COMPOUND; INDOLE; LYSINE; OCTAPEPTIDE; PHENYLALANINE; SOMATOSTATIN; SOMATOSTATIN AGONIST; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 4; SOMATOSTATIN RECEPTOR 5; TRYPTOPHAN; TYROSINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CRYSTAL STRUCTURE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

HUMANS; LIGANDS; MAGNETIC RESONANCE SPECTROSCOPY; MEMBRANE PROTEINS; MODELS, MOLECULAR; OLIGOPEPTIDES; PEPTIDES, CYCLIC; PROTEIN CONFORMATION; RECEPTORS, SOMATOSTATIN; SOMATOSTATIN; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0345735310     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm030246p     Document Type: Article

References (55)

1. Reichlin, S. Somatostatin. N. Engl. J. Med. 1983, 309, 1495-1501.
2. Reichlin, S. Somatostatin (second of two parts). N. Engl. J. Med. 1983, 309, 1556-1563.
3. Delfs, J. R.; Dichter, M. A. Effects of somatostatin on mammalian cortical neurons in culture: physiological actions and unusual dose response characteristics. J. Neurosci. 1983, 3, 1176-88.
4. Iversen, L. L. Nonopioid neuropeptides in mammalian CNS. Annu. Rev. Pharmacol. Toxicol. 1983, 23, 1-27.
5. Patel, Y. C.; Wheatley, T. In vivo and in vitro plasma disappearance and metabolism of somatostatin-28 and somatostatin-14 in the rat. Endocrinology 1983, 112, 220-225.
6. 4-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. J. Med. Chem. 2003, 46, 5579-5586 (in this issue).
7. 4-selective somatostatin (SRIF) agonists. 2. Analogues with β-methyl-3-(2-naphthyl)alanine substitutions at position 8. J. Med. Chem. 2003, 46, 5587-5596 (in this issue).
8. 4-selective somatostatin (SRIF) agonists. 3. Analogues amenable to radiolabeling. J. Med. Chem. 2003, 46, 5597-5605 (in this issue).
9. Lewis, I.; Bauer, W.; Albert, R.; Chandramouli, N.; Pless, J.; Weckbecker, G.; Bruns, C. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential. J. Med. Chem. 2003, 46, 2334-2344.
10. Vale, W.; Rivier, C.; Brown, M.; Rivier, J. Pharmacology of TRF, LRF and somatostatin. Hypothalamic Peptide Hormones and Pituitary Regulation: Advances in Experimental Medicine and Biology; Plenum Press: New York, 1977; pp 123-156.
11. Vale, W.; Rivier, J.; Ling, N.; Brown, M. Biologic and immunologic activities and applications of somatostatin analogs. Metabolism 1978, 27, 1391-1401.
12. Veber, D. F.; Freidinger, R. M.; Perlow, D. S.; Paleveda, W. J., Jr.; Holly, F. W.; Strachan, R. G.; Nutt, R. F.; Arison, B. H.; Homnick, C.; Randall, W. C.; Glitzer, M. S.; Saperstein, R.; Hirschmann, R. A potent cyclic hexapeptide analogue of somatostatin. Nature (London) 1981, 292, 55-58.
13. Pohl, E.; Heine, A.; Sheldrick, G. M.; Dauter, Z.; Wilson, K. S.; Kallen, J.; Huber, W.; Pfaffli, P. J. Structure of octreotide, a somatostatin analogue. Acta Crystallogr. 1995, 51, 48-59.
14. Veber, D. F. Design and discovery in the development of peptide analogs. Peptides: Chemistry and Biology, Proceedings of the 12th American Peptide Symposium, Cambridge, MA, June 16-21, 1991; Smith, J. A., Rivier, J. E., Eds.; ESCOM: Leiden, 1992; pp 1-14.
15. Kessler, H.; Klein, M.; Wagner, K. Peptide conformation. 48. Conformation and biological activity of proline containing cyclic retro-analogues of somatostatin. Int. J. Pept. Protein Res. 1988, 31, 481-498.
16. Mierke, D. F.; Pattaroni, C.; Delaet, N.; Toy, A.; Goodman, M.; Tancredi, T.; Motta, A.; Temussi, P. A.; Moroder, L.; Bovermann, G.; Wünsch, E. Cyclic hexapeptides related to somatostatin. Int. J. Pept. Protein Res. 1990, 36, 418-432.
17. Huang, A.; Pröbstl, A.; Spencer, J. R.; Yamazaki, T.; Goodman, M. Cyclic hexapeptide analogs of somatostatin containing bridge modifications. Int. J. Pept. Protein Res. 1993, 42, 352-365.
18. 1H NMR and computer simulations of cyclic hexapeptides related to somatostatin containing acidic and basic peptoid residues. J. Pept. Res. 1999, 53, 146-160.
19. Mattern, R. H.; Tran, T. A.; Goodman, M. Conformational analyses of cyclic hexapeptide analogs of somatostatin containing arylalkyl peptoid and naphthylalanine residues. J. Pept. Sci. 1999, 5, 161-175.
20. Jaspers, H.; Horváth, A.; Mezö, I.; Kéri, G.; Van Binst, G. Conformational study of a series of somatostatin analogues with antitumor and/or GH inhibitory activity. Int. J. Pept. Protein Res. 1994, 43, 271-276.
21. Hennig, P.; Raimbaud, E.; Thurieau, C.; Volland, J.-P.; Michel, A.; Fauchere, J.-L. Solution conformation by NMR and molecular modeling of three sulfide-free somatostatin octapeptide analogs compared to angiopeptin. J. Comput.-Aided Mol. Des. 1996, 10, 83-86.
22. Gilon, C.; Huenges, M.; Mathä, B.; Gellerman, G.; Hornik, V.; Afargan, M.; Amitay, O.; Ziv, O.; Feller, E.; Gamliel, A.; Shohat, D.; Wanger, M.; Arad, O.; Kessler, H. A backbone-cyclic, receptor 5-selective somatostatin analogue: Synthesis, bioactivity, and nuclear magnetic resonance conformational analysis. J. Med. Chem. 1998, 41, 919-929.
23. Falb, E.; Salitra, Y.; Yechezkel, T.; Bracha, M.; Litman, P.; Olender, R.; Rosenfeld, R.; Senderowitz, H.; Jiang, S.; Goodman, M. A bicyclic and hsst2 selective somatostatin analogue: design, synthesis, conformational analysis and binding. Bioorg. Med. Chem. 2001, 9, 3255-3264.
24. Cheng, R. P.; Suich, D. J.; Cheng, H.; Roder, H.; DeGrado, W. F. Template-constrained somatostatin analogues: a biphenyl linker induces a type-V′ turn. J. Am. Chem. Soc. 2001, 123, 12710-12711.
25. Huang, Z.; He, Y.; Raynor, K.; Tallent, M.; Reisine, T.; Goodman, M. Side chain chiral methylated somatostatin analog synthesis and conformational analysis. J. Am. Chem. Soc. 1992, 114, 9390-9401.
26. Melacini, G.; Zhu, Q.; Osapay, G.; Goodman, M. A refined model for the somatostatin pharmacophore: Conformational analysis of lanthionine-sandostatin analogs. J. Med. Chem. 1997, 40, 2252-2258.
27. 1H 500 MHz nmr spectra and conformational analysis in aqueous solution. Int. J. Pept. Protein Res. 1985, 25, 608-614.
28. Kessler, H.; Haupt, A.; Schudok, M.; Ziegler, K.; Frimmer, M. Peptide conformations. 49(1): synthesis and structure-activity relationships of side chain modified peptides of cyclo(-D-Pro-Phe-Thr-Lys-Trp-Phe-). Int. J. Pept. Protein Res. 1988, 32, 183-193.
29. He, Y.-B.; Huang, Z.; Raynor, K.; Reisine, T.; Goodman, M. Syntheses and conformations of somatostatin-related cyclic hexapeptides incorporating specific alpha and beta-methylated residues. J. Am. Chem. Soc. 1993, 115, 8066-8072.
30. Mattern, R.-H.; Zhang, L.; Rueter, J. K.; Goodman, M. Conformational analyses of sandostatin analogs containing stereo-chemical changes in positions 6 or 8. Biopolymers 2000, 53, 506-522.
31. Jiang, S.; Gazal, S.; Gelerman, G.; Ziv, O.; Karpov, O.; Litman, P.; Bracha, M.; Afargan, M.; Gilon, C.; Goodman, M. A bioactive somatostatin analog without a type II′ beta-turn: synthesis and conformational analysis in solution. J. Pept. Sci. 2001, 7, 521-528.
32. Güntert, P.; Mumenthaler, C.; Wüthrich, K. Torsion angle dynamics for NMR structure calculation with the new program DYANA. J. Mol. Biol. 1997, 273, 283-298.
33. Hagler, A. T.; Dauber, P.; Osguthorpe, D. J.; Hempel, J. C. Dynamics and conformational energetics of a peptide hormone: vasopressin. Science 1985, 227, 1309-1315.
34. Melacini, G.; Zhu, Q.; Goodman, M. Multiconformational NMR analysis of sandostatin (octreotide): Equilibrium between β-sheet and partially helical structures. Biochemistry 1997, 36, 1233-1241.
35. Arison, B. H.; Hirschmann, R.; Veber, D. F. Inferences about the conformation of somatostatin at a biologic receptor based on NMR studies. Biorg. Chem. 1978, 7.
36. Kessler, H.; Griesinger, C.; Lautz, J.; Muller, A.; van Gunsteren, W. F. ; Berendsen, H. J. C. Conformational dynamics detected by nuclear magnetic resonance NOE values and J coupling constants. J. Am. Chem. Soc. 1988, 110, 3393-3396.
37. Mattern, R.-H.; Tran, T.-A.; Goodman, M. Conformational analyses of somatostatin-related cyclic hexapeptides containing peptoid residues. J. Med. Chem. 1998, 41, 2686-2692.
38. Nicolaou, K. C.; Salvino, J. M.; Raynor, K.; Pietranico, S.; Reisine, T. ; Freidinger, R. M.; Hirschmann, R. Design and synthesis of a peptidomimetic employing β-D-glucose for scaffolding. Peptides: Chemistry, Structure and Biology; Proceedings of the 11th American Peptide Symposium, La Jolla, CA, July 9-14, 1989; Rivier, J. E., Marshall, G. R., Eds.; ESCOM Science Publishers B.V.: Leiden, The Netherlands, 1990; pp 881-884.
39. Prasad, V.; Birzin, E. T.; McVaugh, C. T.; Van Rijn, R. D.; Rohrer, S. P.; Chicchi, G.; Underwood, D. J.; Thornton, E. R.; Smith, A. B., III; Hirschmann, R. Effects of heterocyclic aromatic substituents on binding affinities at two distinct sites of somatostatin receptors. Correlation with the electrostatic potential of the substituents. J. Med. Chem. 2003, 46, 1858-1869.
40. Ankersen, M.; Crider, M.; Liu, S.; Ho, B.; Andersen, H. S.; Stidsen, C. Discovery of a novel non-peptide somatostatin agonist with SST4 selectivity. J. Am. Chem. Soc. 1998, 120, 1368-1373.
41. 4 selectivity: Synthesis and structure-activity relationships of thioureas. J. Med. Chem. 1998, 41, 4693-4705.
42. Rohrer, S. P.; Birzin, E. T.; Mosley, R. T.; Berk, S. C.; Hutchins, S. M.; Shen, D.-M.; Xiong, Y.; Hayes, E. C.; Parmar, R. M.; Foor, F.; Mitra, S. W. ; Degrado, S. J.; Shu, M.; Klopp, J. M.; Cai, S.-J.; Blake, A.; Chan, W. W. S.; Pasternak, A.; Yang, L.; Patchett, A. A.; Smith, R. G.; Chapman, K. T.; Schaeffer, J. M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 1998, 282, 737-740.
43. 1H NMR spectra via two-dimensional homonuclear Hartmann-Hahn spectroscopy. J. Am. Chem. Soc. 1985, 107, 2820-2821.
44. Braunschweiler, L.; Ernst, R. R. Coherence transfer by isotropic mixing: Application to proton correlation spectroscopy. J. Magn. Reson. 1983, 53, 521-528.
45. Rance, M.; Sorensen, O. W.; Bodenhausen, B.; Wagner, G.; Ernst, R. R.; Wüthrich, K. Improved spectral resolution in COSY1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983, 117, 479-485.
46. Kumar, A.; Wagner, G.; Ernst, R. R.; Wüthrich, K. Buildup rates of the nuclear Overhauser effect measured by two-dimensional proton magnetic resonance spectroscopy: Implications for studies of protein conformation. J. Am. Chem. Soc. 1981, 103, 3654-3658.
47. Macura, S.; Ernst, R. R. Elucidation of cross-relaxation in liquids by two-dimensional NMR spectroscopy. Mol. Phys. 1980, 41, 95-117.
48. Macura, S.; Huang, Y.; Suter, D.; Ernst, R. R. Two-dimensional chemical exchange and cross-relaxation spectroscopy of coupled nuclear spins. J. Magn. Reson. 1981, 43, 259-281.
49. Güntert, P.; Dotsch, V.; Wider, G.; Wüthrich, K. Processing of multi-dimensional NMR data with the new software PROSA. J. Biolmol. NMR 1992, 2, 619-629.
50. Eccles, C.; Güntert, P.; Billeter, M.; Wüthrich, K. Efficient analysis of protein 2D NMR spectra using the software package EASY. J. Biomol. NMR 1991, 1, 111-130.
51. Wüthrich, K. NMR of Proteins and Nucleic Acids; J. Wiley & Sons: New York, 1986.
52. Maple, J. R.; Thacher, T. S.; Dinur, U.; Hagler, A. T. Biosym force field research results in new techniques for the extraction of inter- and intramolecular forces. Chem. Design Autom. News 1990, 5, 5-10.
53. Koerber, S. C.; Rizo, J.; Struthers, R. S.; Rivier, J. E. Consensus bioactive conformation of cyclic GnRH antagonists defined by NMR and molecular modeling. J. Med. Chem. 2000, 43, 819-828.
54. Hagler, A. T. Theoretical simulation of conformation, energetics and dynamics of peptides. Peptides: Analysis, Synthesis, Biology; Academic Press: Orlando, FL, 1985; pp 213-299.
55. Koradi, R.; Billeter, M. MOLMOL: a program for display and analysis of macromolecular structures. PDB Newsl. 1998, 84, 5-7.